SEC Form 4 · accession 0001179110-19-001088

Tabula Rasa HealthCare, Inc. · TRHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Jan 28, 2019

Accepted (ET)

Jan 30, 2019 · 7:58 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001651561

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 28, 2019	M	1,316	$3.10	A	156,821	D
Common Stock^F2	Jan 28, 2019	S	1,116	$60.24	D	155,705	D
Common Stock^F3	Jan 28, 2019	S	200	$61.33	D	155,505	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$3.10	Jan 28, 2019	M	1,316	D	—	Jun 28, 2023	Common Stock	88,153	86,837	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.47, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnotes (2) and (3) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $61.16 to $61.55, inclusive.
F4The stock option vested 25% on March 21, 2013 and in equal 1/36th installments each month thereafter.